These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 22961206)

  • 1. Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Gui Y; Cai Z
    J Surg Oncol; 2013 Apr; 107(5):555-9. PubMed ID: 22961206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Nie L; Gui Y; Cai Z
    Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Gui Y; Cai Z
    J Surg Oncol; 2013 Feb; 107(2):201-5. PubMed ID: 22766726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression.
    Jiang H; Hu X; Zhang H; Li W
    Radiat Oncol; 2017 Apr; 12(1):65. PubMed ID: 28376901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
    Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
    Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of fascin in migration and invasion of urothelial carcinoma of the bladder.
    Bi JB; Zhu Y; Chen XL; Yu M; Zhang YX; Li BX; Sun JW; Shen HL; Kong CZ
    Urol Int; 2013; 91(2):227-35. PubMed ID: 23428845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma.
    Liang PI; Wu LC; Sheu JJ; Wu TF; Shen KH; Wang YH; Wu WR; Shiue YL; Huang HY; Hsu HP; Chen YH; Chen LT; Li CF; Liao AC
    J Clin Pathol; 2012 Sep; 65(9):802-7. PubMed ID: 22685262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling.
    Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J
    Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer.
    Liao X; Chen J; Liu Y; He A; Wu J; Cheng J; Zhang X; Lv Z; Wang F; Mei H
    Cancer Biomark; 2018 Feb; 21(2):277-285. PubMed ID: 29226855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2.
    Huang MD; Chen WM; Qi FZ; Sun M; Xu TP; Ma P; Shu YQ
    Mol Cancer; 2015 Sep; 14():165. PubMed ID: 26336870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducing cell growth arrest and apoptosis by silencing long non-coding RNA PCAT-1 in human bladder cancer.
    Liu L; Liu Y; Zhuang C; Xu W; Fu X; Lv Z; Wu H; Mou L; Zhao G; Cai Z; Huang W
    Tumour Biol; 2015 Sep; 36(10):7685-9. PubMed ID: 25934337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of bone morphogenetic protein-10 (BMP10) in human urothelial cancer of the bladder and its effects on the aggressiveness of bladder cancer cells in vitro.
    Zhang N; Ye L; Wu L; Deng X; Yang Y; Jiang WG
    Anticancer Res; 2013 May; 33(5):1917-25. PubMed ID: 23645739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study.
    Tsai MC; Li WM; Huang CN; Ke HL; Li CC; Yeh HC; Chan TC; Liang PI; Yeh BW; Wu WJ; Lim SW; Li CF
    Oncotarget; 2016 Nov; 7(48):78918-78931. PubMed ID: 27793038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small interfering RNA targeting heat shock protein 70 enhances chemosensitivity in human bladder cancer cells.
    Behnsawy HM; Miyake H; Kusuda Y; Fujisawa M
    Urol Oncol; 2013 Aug; 31(6):843-8. PubMed ID: 21889367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALKBH3 contributes to survival and angiogenesis of human urothelial carcinoma cells through NADPH oxidase and tweak/Fn14/VEGF signals.
    Shimada K; Fujii T; Tsujikawa K; Anai S; Fujimoto K; Konishi N
    Clin Cancer Res; 2012 Oct; 18(19):5247-55. PubMed ID: 22850567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual role of TGFBR3 in bladder cancer.
    Liu XL; Xiao K; Xue B; Yang D; Lei Z; Shan Y; Zhang HT
    Oncol Rep; 2013 Sep; 30(3):1301-8. PubMed ID: 23835618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tbx3 expression is related to apoptosis and cell proliferation in rat bladder both hyperplastic epithelial cells and carcinoma cells.
    Ito A; Asamoto M; Hokaiwado N; Takahashi S; Shirai T
    Cancer Lett; 2005 Feb; 219(1):105-12. PubMed ID: 15694670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
    Zhang Z; Zhang G; Kong C
    Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of long non-coding RNA Taurine Up-Regulated 1 inhibited doxorubicin resistance of bladder urothelial carcinoma via Wnt/β-catenin pathway.
    Xie D; Zhang H; Hu X; Shang C
    Oncotarget; 2017 Oct; 8(51):88689-88696. PubMed ID: 29179467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
    Caprodossi S; Lucciarini R; Amantini C; Nabissi M; Canesin G; Ballarini P; Di Spilimbergo A; Cardarelli MA; Servi L; Mammana G; Santoni G
    Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.